Maria Concetta Fargnoli

16PUBLICATIONS
91CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 26, 2024
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic.

Alessandro Parisi, Riccardo Giampieri, Silvia Villani

|Oct 19, 2024
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population.

Federica Lo Prinzi, Francesca Salani, Margherita Rimini

|Jul 24, 2023
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers.

Alessandro Parisi, Francesca Rossi, Chiara De Filippis

|Apr 12, 2023
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Luca Cantini, Francesco Paoloni, Federica Pecci

|Feb 25, 2023
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.

Valentina Tuninetti, Eleonora Ghisoni, Sandro Pignata

|Jan 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

Marco Tagliamento, Alessandra Gennari, Matteo Lambertini

Pageof 3

Frequent Collaborators

4 joint publications

Michele Ghidini

4 joint publications

Alessio Cortellini

2 joint publications

Michela Roberto

2 joint publications

Rossana Berardi